Corporate Profile for Exten Industries Inc., dated Friday, Aug. 10, 2001.Business Editors --(BUSINESS WIRE) The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services. -0-
Published Date: Aug. 10, 2001
Company Name: Exten Industries Inc.
Address: 9620 Chesapeake Drive, Suite 201
San Diego, CA 92123
Main Telephone
Number: 858/496-0173
Internet Home
Page Address
(URL) www.exten.com
Chief Executive
Officer: W. Gerald Newmin
Chief Financial
Officer: Gregory Szabo
Investor Relations
Contact: Barbara Corbett
Business number: 858/496-0173
E-mail address: corbett@exten.com
Public Relations
Contact: Barbara Corbett
Business number: 858/496-0173
E-mail address: corbett@exten.com
Industry: Medical
Trading Symbol/
Exchange: OTCBB:EXTI
Market Makers: SCHB, WDCO, FRAN, NDBC, FLTT, GVRC, WIEN, HRZG,
NITE, SLKC, HILL, PGON, LTCO, MHMY, NAIB
Company description: Exten is a medical technology holding company. Its majority owned subsidiary, Xenogenics Corp., is in the R&D stage with the Sybiol(R) synthetic bioliver. This may take several years to get FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approval, so the company has no sales and so has adopted a near term strategy of growth by acquisition. The company's net loss in the fiscal year ended Nov. 30, 2000 was $640,678. The high stock price in that period was $1.26 on Feb. 24, 2000, The low in 2001 was $.076 on July 19, 2001. Additional detail on Xenogenics Corp's. proprietary artificial liver artificial liver Biotech A cartridge with cloned human liver cells, through which blood flows to facilitate removal of waste products. See Extracorporeal liver assist device, Liver dialysis. technology, the Sybiol(R) synthetic bio-liver: It is an external device designed to perform a function for the liver like dialysis dialysis (dīăl`ĭsĭs), in chemistry, transfer of solute (dissolved solids) across a semipermeable membrane. Strictly speaking, dialysis refers only to the transfer of the solute; transfer of the solvent is called osmosis. does for the kidneys by circulating cir·cu·late v. cir·cu·lat·ed, cir·cu·lat·ing, cir·cu·lates v.intr. 1. To move in or flow through a circle or circuit: blood circulating through the body. 2. liver cells through a semi-permeable bio-membrane to interface safely with patients blood. Intended as an adjunct to transplant surgery, it can provide a "bridge" to transplant patients when no donor organ is available, as well as assist patients with chronic liver disease Chronic liver disease is a liver disease of slow process and persisting over a long period of time, resulting in a progressive destruction of the liver. It includes amongst others:
The Sybiol(R) "liver dialysis liver dialysis Therapeutics The use of hepatocytes either in cartridges, as in an bioartificial liver or via cross-perfusion with other organisms, either human or animal origin to provide metabolic support for a Pt in acute hepatic failure. See Artificial liver. " methodology could fill the gap. Projected U.S. market: over $1 billion. Competitors exist; no live-cell artificial liver device is yet on the market. The company believes it has advantages in methodology and structure allowing significant cost and other advantages over competitive technologies presently in development. The company is continually raising funding and hopes to re-initiate preclinical trials Noun 1. preclinical trial - a laboratory test of a new drug or a new invasive medical device on animal subjects; conducted to gather evidence justifying a clinical trial preclinical phase, preclinical test at Loyola University Medical Center Loyola University Medical Center, founded in 1969 by Loyola University as its teaching hospital, is a Level I Trauma Center located in Maywood, Illinois, west of Chicago. The hospital complex includes the Ronald McDonald Children's Hospital and the Joseph Cardinal Bernardin Cancer Center. . After that comes the multi-year multi million process of FDA trials to prove human safety. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion